What is Mannkind's R&D?

Mannkind (MNKD) reported R&D of $17.23M in Q1 2026.

How has Mannkind's R&D changed year-over-year?

Mannkind's R&D increased by 56.3% year-over-year, from $11.02M to $17.23M.

What is the long-term trend for Mannkind's R&D?

Over 4 years (2021 to 2025), Mannkind's R&D has grown at a 52.4% compound annual growth rate (CAGR), from $12.31M to $66.35M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Mannkind MNKD R&D

R&D at other companies

Eli LillyLLY

$3.51B+28.4%

LQD

Liquidia CorporationLQDA

$12.57M+80.5%

Lexicon PharmaceuticalsLXRX

$12.76M-16.6%

Mineralys Therapeutics, Inc.MLYS

$24.37M-35.7%

Tandem Diabetes CareTNDM

$46.04M-8.3%

Eton Pharmaceuticals, Inc.ETON

$1.88M+61.5%

Segments

By segment

See full

All Other Segments$17.23M+56.3%

Other financials

Income statement

See full

Revenue$90.2M+15.1%

Gross profit$82.7M+10.8%

Operating income-$1.7M-107%

Net income-$16.6M-226%

EPS (diluted)-$0.05-225%

Balance sheet

See full

Cash & equivalents$52.8M+11.7%

Total debt$12.2M-9.4%

Total equity-$59.2M-1.0%

Total assets$744.4M+81.5%

Cash flow

See full

Operating cash flow-$5.4M+15.9%

CapEx$1.9M+470%

Free cash flow-$7.2M-8.0%

Valuation

See full

Market cap$1.21B+6.0%

Enterprise value$1.17B+5.5%

P/E233.9×—

P/S3.4×-0.5×

Profitability

See full

Gross margin91.5%-2.6pp

Operating margin23.3%+3.1pp

Net margin9.3%—

FCF margin13.8%—

Returns & leverage

See full

Return on equity-8.8%—

Debt / equity-0.2×—

Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mannkind's R&D?: Mannkind (MNKD) reported R&D of $17.23M in Q1 2026.
How has Mannkind's R&D changed year-over-year?: Mannkind's R&D increased by 56.3% year-over-year, from $11.02M to $17.23M.
What is the long-term trend for Mannkind's R&D?: Over 4 years (2021 to 2025), Mannkind's R&D has grown at a 52.4% compound annual growth rate (CAGR), from $12.31M to $66.35M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.